UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2021
Commission File Number 1-14840
AMDOCS LIMITED
Hirzel House, Smith Street,
St. Peter Port, Island of Guernsey, GY1 2NG
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
FORM 20-F ☒ FORM 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
YES ☐ NO ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
On May 12, 2021, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended March 31, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMDOCS LIMITED | ||
| By: | /s/ Matthew E. Smith | |
| Matthew E. Smith | ||
| Secretary and Authorized Signatory | ||
Date: May 12, 2021
Exhibit 99.1
Amdocs Limited Reports Second Quarter Fiscal 2021 Results
Quarterly Revenue of $1.05 Billion, Exceeding Midpoint of Guidance
Raises Outlook for Accelerated Revenue and Earnings per Share Growth
in Fiscal 2021
Solidifies Cloud Domain Leadership with Acquisition of Sourced Group
Second Quarter Fiscal 2021 Highlights
| • | Revenue of $1,049 million, above the midpoint of the $1,015-$1,055 million guidance range; revenue included a negative impact from foreign currency movements of approximately $1 million compared to our guidance assumptions |
| • | Record managed services revenue of $635 million, equivalent to approximately 61% of total revenue |
| • | GAAP diluted EPS of $0.91, at the midpoint of the $0.87-$0.95 guidance range |
| • | Non-GAAP diluted EPS of $1.13, above the midpoint of the $1.09-$1.15 guidance range |
| • | GAAP operating income of $149 million; GAAP operating margin of 14.2% |
| • | Non-GAAP operating income of $185 million; increased non-GAAP operating margin of 17.6% |
| • | Returned record quarterly cash amount of $403 million to shareholders through share repurchases and quarterly cash dividends, including net proceeds received from the divestiture of OpenMarket |
| • | Quarterly free cash flow of $70 million, comprised of cash flow from operations of $120 million, less $49 million in net capital expenditures and other(1) |
| • | Normalized free cash flow of $133 million(1) |
| • | Twelve-month backlog of $3.54 billion up approximately $50 million sequentially; on a pro forma(2) basis, record twelve-month backlog was up 9.3% as compared to last year’s second fiscal quarter |
| (1) | Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding). |
| (2) | Pro forma growth rate excludes the financial impact of OpenMarket (which was divested on December 31, 2020) from the current fiscal year and comparable fiscal year |
| • | The board of directors approved a quarterly cash dividend of $0.36 per share to be paid on July 23, 2021 |
ST. LOUIS – May 12, 2021 – Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended March 31, 2021.
“I am pleased to report strong results for the second fiscal quarter. Revenue was well above the midpoint of guidance and driven by our best-ever quarter in North America on a pro forma(2) basis where we are seeing healthy activity levels at AT&T, T-Mobile and various other customers across the region. At the operating level, we maintained our focus on consistent project delivery, which translated to healthy cash collections and robust free cash flow generation. Additionally, we returned a record cash amount of more than $400 million to shareholders this quarter, including the net proceeds received from the divesture of OpenMarket, as we had committed to previously,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.
Sheffer continued, “Accelerating the communications industry’s journey to the cloud is core to Amdocs’ future growth and this quarter we took some important steps to further solidify our leadership in this domain. We are today pleased to announce the acquisition of Sourced Group, a leading global technology consultancy specializing in large-scale cloud transformations for sophisticated, high-end enterprise customers in different industries such as communications, financial services and others. Sourced’s proven cloud migration platform, deployment framework and trusted design process, alongside its deep partnerships with Amazon Web Services, Microsoft Azure and Google Cloud Platform, complement our portfolio of cloud-native products and services and further expands and diversifies our customer base.”
Sheffer concluded, “I am pleased to report an improved outlook for revenue and earnings per share growth for the full fiscal year 2021, mainly driven by our expectation for a stronger second half. Our confidence is based on the visibility of our 12-month backlog, which is up more than 9% from a year ago on a pro forma(2) basis. Moreover, we are focused on maintaining our recent sales momentum by executing our growth strategy which we believe is well-aligned with our customer’s multi-year investments in digital modernization, 5G, cloud migration, and next-generation OSS platforms.”
Revenue
Revenue for the second fiscal quarter ended March 31, 2021 was $1,049 million, which on a pro forma basis(2) was up 5.7% in constant currency as compared to last year’s second fiscal quarter. Revenue was down $37 million as reported from the first fiscal quarter of 2021, mainly reflecting the divestiture of OpenMarket on December 31, 2020. Revenue was up 0.1% as reported and down 1.4% in constant currency as compared to last year’s second fiscal quarter. Revenue for the second fiscal quarter of 2021 includes a positive impact from foreign currency movements of approximately $3.3 million relative to the first quarter of fiscal 2021. Revenue was above the midpoint of Amdocs’ guidance, and included negative impact from foreign currency movements of approximately $1 million compared to our guidance assumptions and contributions from recently completed acquisitions of less than $2 million which was not included in our guidance assumptions. Revenue for the second fiscal quarter of 2021 includes record managed services revenue of $635 million, up 5.1% as compared to last year’s second fiscal quarter and equivalent to approximately 61% of total revenue.
Net Income and Earnings Per Share
The Company’s GAAP net income for the second quarter of fiscal 2021 was $119.1 million, or $0.91 per diluted share, compared to GAAP net income of $127.0 million, or $0.94 per diluted share, in the prior fiscal year’s second quarter. Net income on a non-GAAP basis was $148.1 million, or $1.13 per diluted share, compared to non-GAAP net income of $145.7 million, or $1.08 per diluted share, in the second quarter of fiscal 2020. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based compensation expenses, and other, net of related tax effects, in the second quarter of fiscal 2021 as well as in the second quarter of fiscal 2020.
For further details of reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.
Returning Cash to Shareholders
| • | Quarterly Cash Dividend Program: On May 12, 2021, the Board approved the Company’s next quarterly cash dividend payment of $0.36 per share and set June 30, 2021 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 23, 2021. |
| • | Share Repurchase Activity: Repurchased a record $360 million of ordinary shares during the second quarter of fiscal 2021, including the return of the net proceeds from the divestiture of OpenMarket. The board of directors has approved a share repurchase plan authorizing the repurchase of up to $1 billion of ordinary shares at the company’s discretion; this plan has no expiration date and is in addition to the current authorization, which, as of March 31, 2021, provided for up to $228 million of remaining repurchase authorization. Between the two authorizations, we have up to $1.228 billion of remaining repurchase authority. |
Twelve-month Backlog
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.54 billion (excluding OpenMarket) at the end of the second quarter of fiscal 2021. On a pro forma(2) basis, twelve-month backlog was up approximately 9.3% as compared to last year’s second fiscal quarter.
Third Quarter Fiscal 2021 Outlook
| • | Revenue of approximately $1,040-$1,080 million, assuming approximately $3 million sequential negative impact from foreign currency fluctuations as compared to the second quarter of fiscal 2021 and contributions from recently completed acquisitions |
| • | GAAP diluted EPS of approximately $0.91-$0.99. The impact of recent acquisitions on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation |
| • | Non-GAAP diluted EPS of approximately $1.14-$1.20, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.08-$0.10 per share of equity-based compensation expense, net of related tax effects. |
Full Year Fiscal 2021 Outlook
| • | Full year fiscal 2021 revenue guidance reflects the divestiture of OpenMarket as of December 31, 2020 and incorporates an expected positive impact from foreign currency fluctuations of about 1.0% year-over-year as compared with a positive impact of about 1.2% year-over-year previously and a positive contribution from recently completed acquisitions of about 0.5% |
| • | Expects pro forma(2) revenue growth of 5.0%-8.0% year-over-year on a constant currency basis as compared with 3.5%-7.5% year-over-year on a constant currency basis previously |
| • | Expects revenue growth of 1.0%-4.0% year-over-year on a reported basis as compared with (0.3)% -3.7% year-over-year previously |
| • | Expects revenue growth of 0.0%-3.0% year-over-year on a constant currency basis as compared with (1.5)% -2.5% year-over-year previously |
| • | Expects GAAP diluted earnings per share growth of roughly 39.0%-44.0% year-over-year, including gain, net of tax, from divestiture of OpenMarket, as compared with 37.5%-44.5% year-over-year previously. The impact of recent acquisitions on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation |
| • | Expects non-GAAP diluted earnings per share growth of roughly 6.0%-9.0% year-over-year as compared with 4.0%-8.0% year-over-year previously, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, approximately $0.32-$0.36 per share of equity-based compensation expense, and gain from divestiture of OpenMarket, net of related tax effects. The impact of recent acquisitions on Amdocs’ non-GAAP diluted earnings per share is expected to be neutral in the full fiscal year 2021 |
| • | Expects pro forma(2) non-GAAP diluted earnings per share growth of roughly 7.5%-10.5% year-over-year as compared with 5.5%-9.5% year-over-year previously, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, approximately $0.32-$0.36 per share of equity-based compensation expense, and gain from divestiture of OpenMarket, net of related tax effects |
| • | Expects free cash flow of approximately $620 million, comprised of cash flow from operations, less net capital expenditures and other, as compared with $600 million previously |
| • | Expects normalized free cash flow of approximately $820 million as compared with $800 million previously; normalized free cash flow excludes expected capital expenditure of $140 million related to the new campus development in Israel, $40 million of capital gains tax in relation to the divestiture of OpenMarket, and other items |
Our third fiscal quarter 2021 and full year fiscal 2021 outlook takes into consideration the Company’s current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from the COVID-19 pandemic, which has created, and continues to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.
Conference Call Details
Amdocs will host a conference call on May 12, 2021 at 5:00 p.m. Eastern Time to discuss the Company’s second quarter of fiscal 2021 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 3504547. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:
| • | amortization of purchased intangible assets and other acquisition-related costs; |
| • | changes in certain acquisition-related liabilities measured at fair value; |
| • | non-recurring and unusual charges or benefits (such as a gain from divestiture of OpenMarket); |
| • | equity-based compensation expense; |
| • | other; and |
| • | tax effects related to the above. |
Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, non-recurring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
Supporting Resources
| • | Keep up with Amdocs news by visiting the Company’s website |
| • | Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube |
About Amdocs
Amdocs’ purpose is to enrich lives and progress society, using creativity and technology to build a better connected world. Amdocs and its 27,000 employees partner with the leading players in the communications and media industry, enabling next-generation experiences in 85 countries. Our cloud-native, open and dynamic portfolio of digital solutions, platforms and services brings greater choice, faster time to market and flexibility, to better meet the evolving needs of our customers as they drive growth, transform and take their business to the cloud. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.2 billion in fiscal 2020.
For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, the duration and severity of the COVID-19 pandemic, and its impact on the global economy, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that
may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2020 filed on December 14, 2020 and our Form 6-K furnished for the first quarter of fiscal 2021 on February 16, 2021.
Contact:
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com
AMDOCS LIMITED
Consolidated Statements of Income
(In thousands, except per share data)
| Three months ended | Six months ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2021(a) | 2020 | 2021(a) | 2020 | |||||||||||||
| Revenue |
$ | 1,048,734 | $ | 1,047,933 | $ | 2,135,077 | $ | 2,089,890 | ||||||||
| Operating expenses: |
||||||||||||||||
| Cost of revenue |
685,515 | 683,970 | 1,414,231 | 1,370,282 | ||||||||||||
| Research and development |
75,154 | 68,795 | 150,823 | 136,106 | ||||||||||||
| Selling, general and administrative |
116,951 | 119,108 | 238,839 | 242,575 | ||||||||||||
| Amortization of purchased intangible assets and other |
21,870 | 19,348 | 41,740 | 40,638 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| 899,490 | 891,221 | 1,845,633 | 1,789,601 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating income |
149,244 | 156,712 | 289,444 | 300,289 | ||||||||||||
| Interest and other expense, net |
(3,542 | ) | (2,290 | ) | (10,032 | ) | (2,642 | ) | ||||||||
| Gain from sale of a business |
— | — | 226,410 | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before income taxes |
145,702 | 154,422 | 505,822 | 297,647 | ||||||||||||
| Income taxes |
26,635 | 27,384 | 87,123 | 54,677 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 119,067 | $ | 127,038 | $ | 418,699 | $ | 242,970 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Basic earnings per share |
$ | 0.92 | $ | 0.95 | $ | 3.21 | $ | 1.81 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted earnings per share |
$ | 0.91 | $ | 0.94 | $ | 3.19 | $ | 1.80 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Basic weighted average number of shares outstanding |
129,774 | 134,288 | 130,457 | 134,443 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted weighted average number of shares outstanding |
130,696 | 135,059 | 131,147 | 135,339 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Cash dividends declared per share |
$ | 0.36 | $ | 0.3275 | $ | 0.6875 | $ | 0.6125 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
AMDOCS LIMITED
Selected Financial Metrics
(In thousands, except per share data)
| Three months ended | Six months ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2021(a) | 2020 | 2021(a) | 2020 | |||||||||||||
| Revenue |
$ | 1,048,734 | $ | 1,047,933 | $ | 2,135,077 | $ | 2,089,890 | ||||||||
| Non-GAAP operating income |
184,883 | 180,524 | 372,864 | 358,464 | ||||||||||||
| Non-GAAP net income |
148,095 | 145,689 | 301,067 | 289,844 | ||||||||||||
| Non-GAAP diluted earnings per share |
$ | 1.13 | $ | 1.08 | $ | 2.30 | $ | 2.14 | ||||||||
| Diluted weighted average number of shares outstanding |
130,696 | 135,059 | 131,147 | 135,339 | ||||||||||||
Free Cash Flows and Normalized Free Cash Flow
(In thousands)
| Three months ended | Six months ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net Cash Provided by Operating Activities(a) |
$ | 119,736 | $ | 102,868 | $ | 536,221 | $ | 266,776 | ||||||||
| Purchases of property and equipment, net (c) |
(49,245 | ) | (46,170 | ) | (99,310 | ) | (104,705 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Free Cash Flow |
70,491 | 56,698 | 436,911 | 162,071 | ||||||||||||
| Tax payment on sale of business(b) |
25,190 | — | 25,190 | — | ||||||||||||
| Payments of acquisition related liabilities |
13,234 | 1,750 | 13,234 | 1,750 | ||||||||||||
| Payments for previously expensed restructuring charges |
— | 129 | — | 1,645 | ||||||||||||
| Net capital expenditures related to the new campus development |
24,221 | 17,355 | 42,555 | 31,292 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Normalized Free Cash Flow |
$ | 133,136 | $ | 75,932 | $ | 517,890 | $ | 196,758 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (a) | Since January 1, 2021, OpenMarket results are not included in the Consolidated Statements of Income given its divestiture. |
| (b) | Tax payment related to capital gain from divesture of OpenMarket, which was completed on December 31, 2020. |
| (c) | The amounts under “Purchase of property and equipment, net” include proceeds from sale of property and equipment of $136 and $82 for the six months ended March 31, 2021 and 2020, respectively. |
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(In thousands)
| Three months ended March 31, 2021(a) |
||||||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Other | Tax effect |
Non-GAAP | ||||||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||||||
| Cost of revenue |
$ | 685,515 | $ | — | $ | (5,582 | ) | $ | (394 | ) | $ | — | $ | — | $ | 679,539 | ||||||||||||
| Research and development |
75,154 | — | (1,012 | ) | — | — | — | 74,142 | ||||||||||||||||||||
| Selling, general and administrative |
116,951 | — | (6,781 | ) | — | — | — | 110,170 | ||||||||||||||||||||
| Amortization of purchased intangible assets and other |
21,870 | (21,870 | ) | — | — | — | — | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Total operating expenses |
899,490 | (21,870 | ) | (13,375 | ) | (394 | ) | — | — | 863,851 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Operating income |
149,244 | 21,870 | 13,375 | 394 | — | — | 184,883 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Interest and other expense, net |
(3,542 | ) | — | — | — | (375 | ) | — | (3,917 | ) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Income taxes |
26,635 | — | — | — | — | 6,236 | 32,871 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Net income |
$ | 119,067 | $ | 21,870 | $ | 13,375 | $ | 394 | $ | (375 | ) | $ | (6,236 | ) | $ | 148,095 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Three months ended March 31, 2020 |
||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Tax effect |
Non-GAAP | |||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||
| Cost of revenue |
$ | 683,970 | $ | — | $ | (4,693 | ) | $ | 6,284 | $ | — | $ | 685,561 | |||||||||||
| Research and development |
68,795 | — | (723 | ) | — | — | 68,072 | |||||||||||||||||
| Selling, general and administrative |
119,108 | — | (5,332 | ) | — | — | 113,776 | |||||||||||||||||
| Amortization of purchased intangible assets and other |
19,348 | (19,348 | ) | — | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total operating expenses |
891,221 | (19,348 | ) | (10,748 | ) | 6,284 | — | 867,409 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Operating income |
156,712 | 19,348 | 10,748 | (6,284 | ) | — | 180,524 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income taxes |
27,384 | — | — | — | 5,161 | 32,545 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income |
$ | 127,038 | $ | 19,348 | $ | 10,748 | $ | (6,284 | ) | $ | (5,161 | ) | $ | 145,689 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(In thousands)
| Six months ended March 31, 2021(a) |
||||||||||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Gain from sale of a business |
Other | Tax effect |
Non-GAAP | |||||||||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||||||||||
| Cost of revenue |
$ | 1,414,231 | $ | — | $ | (10,523 | ) | $ | (15,728 | ) | $ | — | $ | — | $ | — | $ | 1,387,980 | ||||||||||||||
| Research and development |
150,823 | — | (1,844 | ) | — | — | — | — | 148,979 | |||||||||||||||||||||||
| Selling, general and administrative |
238,839 | — | (13,585 | ) | — | — | — | — | 225,254 | |||||||||||||||||||||||
| Amortization of purchased intangible assets and other |
41,740 | (41,740 | ) | — | — | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total operating expenses |
1,845,633 | (41,740 | ) | (25,952 | ) | (15,728 | ) | — | — | — | 1,762,213 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Operating income |
289,444 | 41,740 | 25,952 | 15,728 | — | — | — | 372,864 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Interest and other expense, net |
(10,032 | ) | — | — | — | — | 824 | — | (9,208 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Gain from sale of a business |
226,410 | — | — | — | (226,410 | ) | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Income taxes |
87,123 | — | — | — | — | — | (24,534 | ) | 62,589 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Net income |
$ | 418,699 | $ | 41,740 | $ | 25,952 | $ | 15,728 | $ | (226,410 | ) | $ | 824 | $ | 24,534 | $ | 301,067 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Six months ended March 31, 2020 |
||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Tax effect |
Non-GAAP | |||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||
| Cost of revenue |
$ | 1,370,282 | $ | — | $ | (10,039 | ) | $ | 3,972 | $ | — | $ | 1,364,215 | |||||||||||
| Research and development |
136,106 | — | (1,526 | ) | — | — | 134,580 | |||||||||||||||||
| Selling, general and administrative |
242,575 | — | (9,944 | ) | — | — | 232,631 | |||||||||||||||||
| Amortization of purchased intangible assets and other |
40,638 | (40,638 | ) | — | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total operating expenses |
1,789,601 | (40,638 | ) | (21,509 | ) | 3,972 | — | 1,731,426 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Operating income |
300,289 | 40,638 | 21,509 | (3,972 | ) | — | 358,464 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income taxes |
54,677 | — | — | — | 11,301 | 65,978 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income |
$ | 242,970 | $ | 40,638 | $ | 21,509 | $ | (3,972 | ) | $ | (11,301 | ) | $ | 289,844 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(In thousands)
| As of | ||||||||
| March 31, 2021 |
September 30, 2020 |
|||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash and cash equivalents |
$ | 968,988 | $ | 983,188 | ||||
| Short-term interest-bearing investments |
194,684 | 752 | ||||||
| Accounts receivable, net, including unbilled of $172,301 and $175,548, respectively |
907,017 | 861,033 | ||||||
| Prepaid expenses and other current assets |
227,560 | 229,604 | ||||||
|
|
|
|
|
|||||
| Total current assets |
2,298,249 | 2,074,577 | ||||||
| Property and equipment, net |
640,253 | 607,951 | ||||||
| Lease assets |
266,719 | 295,494 | ||||||
| Goodwill and other intangible assets, net |
2,883,646 | 2,874,979 | ||||||
| Other noncurrent assets |
513,219 | 488,620 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 6,602,086 | $ | 6,341,621 | ||||
|
|
|
|
|
|||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
| Current liabilities |
||||||||
| Accounts payable, accruals and other |
$ | 961,670 | $ | 930,259 | ||||
| Short-term financing arrangement |
100,000 | 100,000 | ||||||
| Lease liabilities |
58,794 | 59,100 | ||||||
| Deferred revenue |
219,199 | 126,841 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
1,339,663 | 1,216,200 | ||||||
| Lease liabilities |
209,276 | 230,076 | ||||||
| Long-term debt, net of unamortized debt issuance costs |
644,276 | 644,023 | ||||||
| Other noncurrent liabilities |
762,133 | 586,167 | ||||||
| Total Amdocs Limited Shareholders’ equity |
3,604,229 | 3,622,646 | ||||||
| Noncontrolling interests |
42,509 | 42,509 | ||||||
|
|
|
|
|
|||||
| Total equity |
3,646,738 | 3,665,155 | ||||||
|
|
|
|
|
|||||
| Total liabilities and equity |
$ | 6,602,086 | $ | 6,341,621 | ||||
|
|
|
|
|
|||||
AMDOCS LIMITED
Consolidated Statements of Cash Flows
(In thousands)
| Six months ended March 31, |
||||||||
| 2021 | 2020 | |||||||
| Cash Flow from Operating Activities: |
||||||||
| Net income(a) |
$ | 418,699 | $ | 242,970 | ||||
| Reconciliation of net income to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
101,298 | 98,107 | ||||||
| Amortization of debt issuance costs |
272 | — | ||||||
| Equity-based compensation expense |
25,952 | 21,509 | ||||||
| Gain from sale of a business |
(226,410 | ) | — | |||||
| Deferred income taxes |
(27,778 | ) | 9,150 | |||||
| Loss from short-term interest-bearing investments |
221 | — | ||||||
| Net changes in operating assets and liabilities, net of amounts acquired: |
||||||||
| Accounts receivable, net |
(108,799 | ) | 19,957 | |||||
| Prepaid expenses and other current assets |
(11,906 | ) | (22,637 | ) | ||||
| Other noncurrent assets |
(10,763 | ) | (1,653 | ) | ||||
| Lease assets and liabilities, net |
7,522 | (11,947 | ) | |||||
| Accounts payable, accrued expenses and accrued personnel |
76,427 | (96,647 | ) | |||||
| Deferred revenue |
226,904 | 17,616 | ||||||
| Income taxes payable, net |
41,629 | 7,853 | ||||||
| Other noncurrent liabilities |
22,953 | (17,502 | ) | |||||
|
|
|
|
|
|||||
| Net cash provided by operating activities |
536,221 | 266,776 | ||||||
|
|
|
|
|
|||||
| Cash Flow from Investing Activities: |
||||||||
| Purchase of property and equipment, net (c) |
(99,310 | ) | (104,705 | ) | ||||
| Proceeds from sale of short-term interest-bearing investments |
4,258 | — | ||||||
| Purchase of short-term interest-bearing investments |
(200,088 | ) | — | |||||
| Net cash paid for business and intangible assets acquisitions |
(87,600 | ) | — | |||||
| Net cash received from sale of a business |
290,789 | — | ||||||
| Other |
562 | (3,273 | ) | |||||
|
|
|
|
|
|||||
| Net cash used in investing activities |
(91,389 | ) | (107,978 | ) | ||||
|
|
|
|
|
|||||
| Cash Flow from Financing Activities: |
||||||||
| Borrowings under financing arrangements |
— | 350,000 | ||||||
| Repurchase of shares |
(450,074 | ) | (210,048 | ) | ||||
| Proceeds from employee stock options exercises |
78,438 | 70,639 | ||||||
| Payments of dividends |
(85,934 | ) | (76,770 | ) | ||||
| Payment of contingent consideration from a business acquisition |
(1,462 | ) | (1,411 | ) | ||||
| Other |
— | (238 | ) | |||||
|
|
|
|
|
|||||
| Net cash (used in) provided by financing activities |
(459,032 | ) | 132,172 | |||||
|
|
|
|
|
|||||
| Net (decrease) increase in cash and cash equivalents |
(14,200 | ) | 290,970 | |||||
| Cash and cash equivalents at beginning of period |
983,188 | 471,632 | ||||||
|
|
|
|
|
|||||
| Cash and cash equivalents at end of period |
$ | 968,988 | $ | 762,602 | ||||
|
|
|
|
|
|||||
AMDOCS LIMITED
Supplementary Information
(In millions)
| Three months ended | ||||||||||||||||||||
| March 31, 2021(a) |
December 31, 2020 |
September 30, 2020 |
June 30, 2020 |
March 31, 2020 |
||||||||||||||||
| North America |
$ | 679.1 | $ | 703.4 | $ | 681.6 | $ | 685.9 | $ | 691.3 | ||||||||||
| Europe |
148.8 | 171.6 | 165.3 | 145.4 | 148.3 | |||||||||||||||
| Rest of the World |
220.8 | 211.3 | 206.0 | 194.9 | 208.3 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Total Revenue |
$ | 1,048.7 | $ | 1,086.3 | $ | 1,052.9 | $ | 1,026.2 | $ | 1,047.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Three months ended | ||||||||||||||||||||
| March 31, 2021 |
December 31, 2020 |
September 30, 2020 |
June 30, 2020 |
March 31, 2020 |
||||||||||||||||
| Managed Services Revenue |
$ | 634.6 | $ | 623.7 | $ | 610.5 | $ | 604.5 | $ | 604.0 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| As of | ||||||||||||||||||||
| March 31, 2021(d) |
December 31, 2020(d) |
September 30, 2020 |
June 30, 2020 |
March 31, 2020 |
||||||||||||||||
| 12-Month Backlog |
$ | 3,540 | $ | 3,490 | $ | 3,620 | $ | 3,480 | $ | 3,460 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (d) | Excludes OpenMarket |
# # #